NAMA
Nikko Asset Management Americas’s 10x Genomics TXG Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $69.5M | Buy |
6,009,653
+646,997
| +12% | +$7.49M | 0.69% | 38 |
|
|
2025
Q1 | $46.8M | Sell |
5,362,656
-350,828
| -6% | -$3.06M | 0.6% | 42 |
|
|
2024
Q4 | $82M | Sell |
5,713,484
-659,728
| -10% | -$9.47M | 0.89% | 32 |
|
|
2024
Q3 | $144M | Buy |
6,373,212
+224,960
| +4% | +$5.08M | 1.63% | 18 |
|
|
2024
Q2 | $119M | Buy |
6,148,252
+2,526,474
| +70% | +$49M | 1.38% | 23 |
|
|
2024
Q1 | $136M | Buy |
3,621,778
+1,338,248
| +59% | +$50.2M | 1.35% | 21 |
|
|
2023
Q4 | $128M | Buy |
2,283,530
+565,059
| +33% | +$31.6M | 1.23% | 23 |
|
|
2023
Q3 | $70.9M | Sell |
1,718,471
-47,163
| -3% | -$1.95M | 0.85% | 28 |
|
|
2023
Q2 | $98.6M | Sell |
1,765,634
-255,435
| -13% | -$14.3M | 1.04% | 25 |
|
|
2023
Q1 | $110M | Sell |
2,021,069
-156,919
| -7% | -$8.51M | 1.26% | 22 |
|
|
2022
Q4 | $79.4M | Sell |
2,177,988
-29,270
| -1% | -$1.07M | 1.14% | 23 |
|
|
2022
Q3 | $61.1M | Buy |
2,207,258
+793,419
| +56% | +$22M | 0.78% | 28 |
|
|
2022
Q2 | $56.6M | Sell |
1,413,839
-17,934
| -1% | -$717K | 0.7% | 33 |
|
|
2022
Q1 | $109M | Buy |
1,431,773
+183,813
| +15% | +$14M | 0.8% | 28 |
|
|
2021
Q4 | $166M | Sell |
1,247,960
-85,584
| -6% | -$11.4M | 0.87% | 30 |
|
|
2021
Q3 | $192M | Sell |
1,333,544
-208,044
| -13% | -$29.9M | 0.82% | 34 |
|
|
2021
Q2 | $299M | Buy |
1,541,588
+498,675
| +48% | +$96.8M | 1.17% | 27 |
|
|
2021
Q1 | $189M | Buy |
1,042,913
+924,534
| +781% | +$167M | 0.92% | 35 |
|
|
2020
Q4 | $16.8M | Buy |
118,379
+16,111
| +16% | +$2.28M | 0.1% | 108 |
|
|
2020
Q3 | $12.2M | Sell |
102,268
-103,945
| -50% | -$12.4M | 0.11% | 103 |
|
|
2020
Q2 | $17.8M | Buy |
+206,213
| New | +$17.8M | 0.23% | 65 |
|